Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations - Schedule of Discontinued Operation of Balance Sheet and Operation Statement (Details)

v3.20.2
Discontinued Operations - Schedule of Discontinued Operation of Balance Sheet and Operation Statement (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Cash $ 29,301   $ 29,301   $ 17,767
Accounts receivable, net 177,144   177,144   482,472
Prepaid expenses and other current assets 3,433   3,433   5,150
Current assets classified as held for sale 209,878   209,878   505,389
Property and equipment, net 2,140   2,140   3,354
Deposits     6,029
Non-current assets classified as held for sale 2,140   2,140   9,383
Accounts payable 846,941   846,941   1,160,101
Accrued expenses 1,322,044   1,322,044   1,376,127
Current portion of notes payable 134,118   134,118   256,274
Current liabilities classified as held for sale 2,303,103   2,303,103   2,792,502
Revenue from services 103,110 $ 376,880 262,178 $ 519,951  
Cost of services 2,212 38,409 10,989 87,254  
Gross profit 100,898 338,471 251,189 432,697  
Operating expenses 67,431 480,720 251,200 1,057,595  
Other expense 17,294 3,002 23,591 28,962  
Provision for income taxes  
Loss from Discontinued Operations 16,173 (145,251) (23,602) (653,860)  
Advanced Molecular Services Group [Member]          
Cash 1,093   1,093   452
Accounts receivable, net    
Prepaid expenses and other current assets    
Current assets classified as held for sale 1,093   1,093   452
Property and equipment, net    
Deposits    
Non-current assets classified as held for sale    
Accounts payable 491,566   491,566   491,206
Accrued expenses 544,410   544,410   565,943
Current portion of notes payable 134,118   134,118   256,274
Current liabilities classified as held for sale 1,170,094   1,170,094   1,313,423
Revenue from services 25,500 48,482  
Cost of services 7,105 23,760  
Gross profit 18,395 24,722  
Operating expenses 14,624 74,008 15,587 176,618  
Other expense 17,294 3,002 23,591 28,962  
Provision for income taxes  
Loss from Discontinued Operations (31,918) (58,615) (39,178) (180,858)  
Health Technology Solutions, Inc [Member]          
Cash 28,208   28,208   17,315
Accounts receivable, net 177,144   177,144   482,472
Prepaid expenses and other current assets 3,433   3,433   5,150
Current assets classified as held for sale 208,785   208,785   504,937
Property and equipment, net 2,140   2,140   3,354
Deposits     6,029
Non-current assets classified as held for sale 2,140   2,140   9,383
Accounts payable 355,375   355,375   668,895
Accrued expenses 777,634   777,634   810,184
Current liabilities classified as held for sale 1,133,009   1,133,009   $ 1,479,079
Revenue from services 103,110 351,380 262,178 471,469  
Cost of services 2,212 31,304 10,989 63,494  
Gross profit 100,898 320,076 251,189 407,975  
Operating expenses 52,807 406,712 235,613 880,977  
Other expense  
Provision for income taxes  
Loss from Discontinued Operations $ 48,091 $ (86,636) $ 15,576 $ (473,002)